Autres langues Sonoma Pharmaceuticals, Inc.

Actions

SNOA

US83558L2043

Marché Fermé - Nasdaq Autres places de cotation 22:30:01 03/05/2024			Varia. 5j.	Varia. 1 janv.
0,156 ^USD	+1,89%		-1,89%	-13,53%

08/02	Sonoma Pharmaceuticals, Inc. annonce ses résultats pour le troisième trimestre et les neuf mois se terminant le 31 décembre 2023	CI
23/01	Sonoma Pharmaceuticals lance Lumacyn Clarifying Mist, un produit de soin de la peau entièrement naturel, en vente libre, pour un usage quotidien.	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States	10/04
Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections	05/04
Sonoma Pharmaceuticals Highlights Safety Advantages of its Microcyn Products in Light of Growing Concerns of Benzene in Many Other Topicals	28/03
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial Results	09/02
Sonoma Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	08/02
Sonoma Pharmaceuticals Introduces Lumacyn Clarifying Mist, an All Natural, Over-The-Counter Skincare Product for Daily Use	23/01
NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union through Sonoma's Extensive Distributor Network	10/01
NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma?s Extensive Distributor Network	09/01
Sonoma Pharmaceuticals : Material Agreement - Form 8-K	18/12
Sonoma Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	13/11
Sonoma Pharmaceuticals, Inc. Announces U.S. Launch of Next Generation Advanced Solution for Pulse Lavage Irrigation At the Symposium on Advanced Wound Care Fall Conference	03/11
Sector Update: Health Care Stocks Ease in Late Afternoon	26/10/23
Sector Update: Health Care	26/10/23
Top MIdday Decliners	26/10/23
Wall Street Set to Open Lower as GDP, Jobless Claims Higher Than Expected	26/10/23
Sonoma Pharmaceuticals : Investor Presentation October 2023 - Form 8-K	11/10/23
National Eczema Association Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced	16/08/23
National Eczema Association Awards Seal of Acceptance to Sonoma Pharmaceuticals, Inc. for Reliefacyn Advanced	15/08/23
Sonoma Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023	10/08/23
Sonoma Pharmaceuticals, Inc. Announces Appointment of Hye Jin Chung to Scientific Advisory Board	03/08/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Sonoma Pharmaceuticals, Inc.

Actions

SNOA

US83558L2043

Autres langues

Filtres